A novel explainable AI for revealing determinants of cancer drug response through integrative multi-omics analysis
-
By
-
Shynu Padinjappurathu Gopalan
-
Vino Sundararajan
-
May 18, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Genomics of Drug Sensitivity in Cancer 2 (GDSC2)
N/A, N/A
Key Differentiators
- Oncology
-
#2
The University of Texas MD Anderson Cancer Center
Houston, Texas
Key Differentiators
- Oncology
-
#3
City of Hope
Duarte, California
Key Differentiators
- Oncology
-
#4
Mayo Clinic
Rochester, Minnesota
Key Differentiators
- Oncology
-
#5
University of Cologne
Cologne, North Rhine-Westphalia
Key Differentiators
- Oncology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.